BOLD Prakiraan wutah bathi resik saben saham ing taun iki Boundless Bio, Inc.
Clinical research outsourcing allows Boundless Bio, Inc. (BOLD) to focus on innovation, as evidenced by the annual net income per share trend, where the latest value is recorded as 2.70. Business growth is based on the validation of the ecDNA platform and new patents. Meanwhile, the company complies with environmental regulations for chemical waste disposal, minimizing the footprint of its laboratory developments.
Rincian metrik keuangan lan pasar Boundless Bio, Inc. (BOLD)
- nilai saham lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data nilai buku modal saham:
- rincian utang lan likuiditas:
Utang marang Ekuitas Boundless Bio, Inc.|BOLD - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal boundlessbio.com|BOLD - Utang perusahaan|Utang-utang marang nilai buku Boundless Bio Inc|BOLD - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Boundless Bio|Koefisien jangkoan perantara boundlessbio.com
- data bathi lan kelipatan valuasi:
BOLD - Bathi resik perusahaan|Prakiraan bathi resik Boundless Bio, Inc.|BOLD - Pangali P/E|Prakiraan rega marang bathi Boundless Bio Inc|BOLD - Pangali rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Boundless Bio Inc|BOLD - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Boundless Bio|BOLD - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan boundlessbio.com|BOLD - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Boundless Bio, Inc.
Analisis dhasar perusahaan:BOLD Boundless Bio Inc.
This indicator reflects the year-over-year dynamics of net income per share. Analyzing this rate allows an investor to assess business resilience to market shocks and the efficiency of capital management. The trend, represented by measured EPS YoY growth, reveals acceleration phases in operational processes. For Boundless Bio, Inc. (BOLD), such metrics correlate with investments in R&D personnel specializing in oncogenomics. Retaining key scientists through stock options provides the fundamental basis for future profit growth.
Pesaing wigati
Kacepetan wutah bathi saben saham ing taun lumaku Tempus Labs (TEM)|Wutah bathi saben saham ing taun lumaku Qiagen Group|Isis Pharmaceuticals (IONS) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Repligen Corporation (RGEN)|Prakiraan wutah bathi resik saben saham ing taun iki aviditybiosciences.com|CRISPR Therapeutics - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku WGS|Ultragenyx Pharma - Wutah bathi ing taun lumaku|BEAM: Wutah bathi saben saham ing taun lumaku|SRPT: Wutah bathi ing taun lumaku|TWST - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku 10x Genomics|Kacepetan wutah bathi saben saham ing taun lumaku Intellia Therapeutics Inc NTLA|Wutah bathi resik saben saham ing taun iki STOK (Stoke)|BLFS (BioLife) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku WVE (Wave Life Sciences)|Prakiraan wutah bathi resik saben saham ing taun iki mazetx.com (MAZE)|SION - Wutah bathi saben saham ing taun lumaku|PRME (Prime Medicine Inc) - Wutah bathi saben saham ing taun iki|TSHA: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki uniQure Pharma|Wutah bathi resik saben saham ing taun iki MGTX|regenxbio.com (RGNX) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku SLDB|Wutah bathi saben saham ing taun lumaku OCGN (Ocugen Inc)|Wutah bathi saben saham ing taun lumaku Pacific Biosciences of California PACB|Benitec Corp (BNTC) - Kacepetan wutah bathi saben saham ing taun lumaku|DSGN - Wutah bathi saben saham ing taun lumaku|RCKT: Wutah bathi saben saham ing taun lumaku|FDMT: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki LXEO|KRRO (Korro Bio Inc.) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki EDIT (Editas Corp)|Wutah bathi saben saham ing taun lumaku Silence Therapeutics (SLN)|proqr.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku CDXS (Codexis)|Wutah bathi ing taun lumaku Sangamo Therapeutics Inc. SGMO|Nautilus Biotechnology Inc - Wutah bathi ing taun lumaku|MGX: Wutah bathi saben saham ing taun lumaku|Precision BioSciences, Inc. (DTIL) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Generation Bio (GBIO)|Wutah bathi resik saben saham ing taun iki XCUR|Wutah bathi ing taun lumaku Celsion Corporation|Wutah bathi saben saham ing taun lumaku Phio Pharmaceuticals (PHIO)|mustangbio.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku RNAZ (TransCode Therapeutics, Inc.)|BNGO: Wutah bathi saben saham ing taun iki|APDN - Wutah bathi saben saham ing taun lumaku|BLUE: Wutah bathi saben saham ing taun lumaku|IPA: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Omega Therapeutics Corp (OMGA)|Wutah bathi saben saham ing taun lumaku Singular Genomics Systems|regulusrx.com (RGLS) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Syros Pharmaceuticals, Inc. (SYRS)|Prakiraan wutah bathi resik saben saham ing taun iki Telesis Bio Inc.|TRACON - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku UBX
